| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/02/2009 | WO2009080198A1 Fused cynopryridines and the use thereof |
| 07/02/2009 | US20090171112 Urea derivative and process for preparing the same |
| 07/02/2009 | US20090171092 Process for the Preparation of Montelukast and Its Pharmaceutically Acceptable Salts |
| 07/02/2009 | US20090171091 Compounds suitable as modulators of hdl |
| 07/02/2009 | US20090170896 c-Met modulators and methods of use |
| 07/02/2009 | US20090169609 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/02/2009 | US20090165858 Dye-sensitized photoelectric conversion device |
| 07/02/2009 | CA2708450A1 Method for producing conjugated aromatic compound |
| 07/02/2009 | CA2704268A1 Receptor targeting ligands |
| 07/01/2009 | EP2075310A1 Organic electroluminescent device material and organic electroluminescent device |
| 07/01/2009 | EP2074111A2 Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| 07/01/2009 | EP2074099A1 Quinolinone derivatives |
| 07/01/2009 | EP2074098A2 Quinoline compounds |
| 07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
| 07/01/2009 | EP2073807A1 Pharmaceutical combinations |
| 07/01/2009 | EP1646612B1 Processes for preparing montelukast sodium |
| 07/01/2009 | CN201264977Y Continuous treater for ethoxyquin synthetic liquid |
| 07/01/2009 | CN101468966A Quinoline zinc luminescent material and electroluminescent devices including the same |
| 07/01/2009 | CN100506796C Method for preparing high optical purity pitavastatin calcium raw material drug |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553967 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553854 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 06/30/2009 | US7553853 crystalline or amorphous form of R-(E)]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropane acetic acid and/or sodium salt, used for the treatment of asthma |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553848 Vanilloid receptor ligands and their use in treatments |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/30/2009 | CA2406088C Novel phenyl-propargylether derivatives |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090163523 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
| 06/25/2009 | US20090162694 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 06/25/2009 | DE102007061764A1 Anellierte Cyanopyridine und ihre Verwendung Fused cyanopyridines and their use |
| 06/25/2009 | DE102007061630A1 Preparing montelukast sodium, useful e.g. to antagonize leukotriene, comprises reacting sodium alkoxide compound with montelukast acid in organic solvent, where the montelukast acid is obtained by acidifying montelukast cyclohexylamine |
| 06/24/2009 | EP2072509A1 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents |
| 06/24/2009 | EP2072502A1 Sulfoximide substituted chinolin and chinazolin derivatives as kinase inhibitors |
| 06/24/2009 | EP1599450B1 Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salts, useful as adrenoceptor agonists |
| 06/24/2009 | CN101466682A 4-anilinoquinolina-3-carboxamidas como inhibidores de la quinasa CSF-1R |
| 06/24/2009 | CN101466681A Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 06/24/2009 | CN101466680A Process for synthesizing piperazine-piperidine compounds |
| 06/24/2009 | CN101466679A A process for preparing tetrahydroquinoline derivatives |
| 06/24/2009 | CN101463005A Method for purifying rebamipide crude product |
| 06/23/2009 | US7550598 Kinase inhibitors |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550596 Via liquid chromatography using packing material comprising carrier and polysaccharide, where part or all of hydrogen atoms of hydroxyl and amino groups of polysaccharide are substituted with substituents such as a carbamoyl group where one hydrogen is substituted with aromatic group with specific alkyl |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride |
| 06/23/2009 | US7550483 High usability as medicaments; useful as an angiogenesis inhibitor or a c-Kit kinase inhibitor; prepared by dissolving a crystalline form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide methanesulfonate in an alcohol and water |
| 06/23/2009 | US7550482 Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 06/23/2009 | US7550480 1,8-naphthyridin-2(1H)-ones; treating CSBP/p38 kinase mediated diseases; cytokine suppressive anti-inflammatory drugs |
| 06/23/2009 | US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents |
| 06/23/2009 | US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/23/2009 | US7550453 Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2214131C Trisubstituted phenyl derivatives |
| 06/18/2009 | WO2009076173A2 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | WO2009075250A1 Plant disease control agent |
| 06/18/2009 | WO2009074733A2 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 06/18/2009 | US20090156813 Methods of preparing aripiprazole crystalline forms |
| 06/18/2009 | US20090156605 Quinolones and azaquinolones that inhbit prolyl hydroxylase |
| 06/18/2009 | US20090156600 Quinolines and Their Therapeutic Use |
| 06/18/2009 | US20090156594 Heterocyclic kinase modulators |
| 06/18/2009 | US20090153039 Green electroluminescent compounds and organic electroluminescent device using the same |
| 06/17/2009 | EP2069307A2 Process for the preparation of montelukast and its salts thereof |
| 06/17/2009 | EP2069306A1 Quinolinylmethyl compounds |
| 06/17/2009 | EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
| 06/17/2009 | EP2069280A2 Process and intermediates for preparing integrase inhibitors |
| 06/17/2009 | EP2068877A2 Compounds and methods of modulating angiogenesis |
| 06/17/2009 | EP2068876A2 Aqueous formulation comprising an antitumor agent |
| 06/17/2009 | EP2068875A2 Compositions and methods for modulating sirtuin activity |
| 06/17/2009 | EP2068632A1 Fungicides |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | CN101460464A Pyrrolidine derivatives useful as BACE inhibitors |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/16/2009 | US7547787 Processes for preparing montelukast sodium |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/16/2009 | US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/16/2009 | US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 06/11/2009 | WO2009073550A2 Substituted tetrahydroquinolines as antibacterial agents |
| 06/11/2009 | WO2009053895A3 Quinoline urotensin-ii receptor antagonists |
| 06/11/2009 | US20090149491 Carbocyclic oxime hepatitis c virus serine protease inhibitors |
| 06/11/2009 | US20090149444 Benzylamine analogues |
| 06/10/2009 | EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 06/10/2009 | EP2066639A1 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 06/10/2009 | EP2066638A1 Process for the purification of montelukast |
| 06/10/2009 | CN101454288A Benzofluoranthene compound and organic light-emitting element using the same |
| 06/10/2009 | CN101450927A Benzoic acid derivates containing oxo pyridine substituted propionamido |
| 06/10/2009 | CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 06/10/2009 | CN100497312C Preparation method of 5,6,7,8-tetrahydroquinoline |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544805 Hydrophobic; storage stability; coprecipitate of amorphous montelukast sodium and lactose prepared by freeze-drying and pressing at 10,000 Kg/cm3 for 1 minute; spray drying from an aqueous solution; relatively high bulk density; materials handling |
| 06/09/2009 | US7544804 Colorant compositions |
| 06/09/2009 | US7544803 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders |
| 06/09/2009 | US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |